NATb/NAT1*4 promotes greater arylamine N -acetyltransferase 1 mediated DNA adducts and mutations than NATa/NAT1*4 following exposure to 4-aminobiphenyl-Reference-Cited by-同舟云学术

NATb/NAT1*4 promotes greater arylamine N -acetyltransferase 1 mediated DNA adducts and mutations than NATa/NAT1*4 following exposure to 4-aminobiphenyl

Published:2011-08-11 Issue:8 Volume:51 Page:636-646
ISSN:0899-1987
Container-title:Molecular Carcinogenesis
language:en
Short-container-title:Mol. Carcinog.

Author:

Millner Lori M.,Doll Mark A.,Cai Jian,States J. Christopher,Hein David W.

Publisher

Wiley

Subject

Cancer Research,Molecular Biology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/mc.20836/fullpdf

Reference51 articles.

1. International Agency for Research on Cancer Overall evaluation of carcinogenicity: An update of IARC monographs, Supplement 7, Vols. 1-42 1987

2. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases;Hein;Carcinogenesis,1993

3. Deletion of a xenobiotic metabolizing gene in mice affects folate metabolism;Wakefield;Biochem Biophys Res Commun,2007

4. The NAT1 C1095A polymorphism, maternal multivitamin use and smoking, and the risk of spina bifida;Jensen;Birth Defects Res A Clin Mol Teratol,2005

5. Maternal smoking and the risk of orofacial clefts: Susceptibility with NAT1 and NAT2 polymorphisms;Lammer;Epidemiology,2004

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Arylamine N-Acetyltransferases;Reference Module in Biomedical Sciences;2024

2. Acetyl coenzyme A kinetic studies on N-acetylation of environmental carcinogens by human N-acetyltransferase 1 and its NAT1*14B variant;Frontiers in Pharmacology;2022-10-28

3. N-acetyltransferase 2 genetic polymorphism modifies genotoxic and oxidative damage from new psychoactive substances;Archives of Toxicology;2022-09-23

4. Human N-Acetyltransferase 1 and 2 Differ in Affinity Towards Acetyl-Coenzyme A Cofactor and N-Hydroxy-Arylamine Carcinogens;Frontiers in Pharmacology;2022-02-25

5. Identification and characterization of potent, selective, and efficacious inhibitors of human arylamine N-acetyltransferase 1;Archives of Toxicology;2021-11-16